There is abundant evidence that clinical chemistry laboratory tests ar
e over-ordered in North America, but there does not seem to be an effe
ctive corrective strategy that has a prolonged effect, The goal of thi
s study was to design one that had a prolonged effect. Using a pre- an
d post-intervention survey study design, the authors observed the effe
ct of physician education followed by a ban on test-panel ordering of
common clinical chemistry tests, reinforced by written reminders to ph
ysicians not heeding the ban, on ordering patterns (tests per specimen
), and total numbers of these tests ordered. Panels of >16 common bioc
hemistry tests per specimen were reduced from 15% to 6% of orders for
inpatients and from 44% to 11% for outpatients 1 year after the implem
entation of the ban on test-panel ordering, However, the ban had littl
e effect on the ordering rates for panels of 7 common tests, Education
al exercises (newsletters and lectures) had no effect. The authors con
clude that a ban on test-panel (profile) ordering reinforced by contin
uing reminders to nonconforming physicians is an effective means of re
ducing clinical chemistry test usage over the long term, A 38% reducti
on of common biochemistry tests ordered was achieved, However, overall
costs savings were modest, Nevertheless, the authors conclude that th
e cost-effective use of the clinical pathology laboratory by careful s
election of tests is an essential part of a medical trainee's educatio
n.